Cargando…
N-glycolylneuraminic acid as a carbohydrate cancer biomarker
One of the forms of aberrant glycosylation in human tumors is the expression of N-glycolylneuraminic acid (Neu5Gc). The only known enzyme to biosynthesize Neu5Gc in mammals, cytidine-5′-monophosphate-N-acetylneuraminic acid (CMAH), appears to be genetically inactivated in humans. Regardless, low lev...
Autores principales: | Wang, Jing, Shewell, Lucy K., Day, Christopher J., Jennings, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971276/ https://www.ncbi.nlm.nih.gov/pubmed/36805917 http://dx.doi.org/10.1016/j.tranon.2023.101643 |
Ejemplares similares
-
N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
por: Shewell, Lucy K., et al.
Publicado: (2022) -
Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma
por: Akimoto, Shuji, et al.
Publicado: (2023) -
Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
por: Yehuda, Sharon, et al.
Publicado: (2020) -
N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses
por: Broszeit, Frederik, et al.
Publicado: (2019) -
N-Glycolylneuraminic Acid in Animal Models for Human Influenza A Virus
por: Spruit, Cindy M., et al.
Publicado: (2021)